DaVita (NYSE:DVA – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share guidance of 9.000-9.800 for the period, compared to the consensus earnings per share estimate of 9.010. The company issued revenue guidance of -. DaVita Stock Performance Shares of NYSE:DVA traded up $2.42 during trading on […]
DaVita (NYSE:DVA – Get Free Report) posted its earnings results on Thursday. The company reported $2.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.95 by $0.43, RTT News reports. DaVita had a return on equity of 64.42% and a net margin of 5.70%. The firm had revenue of $3.07 billion […]
DaVita (NYSE:DVA – Get Free Report) and Global Cord Blood (NYSE:CORBF – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk and analyst recommendations. Volatility & Risk DaVita has a beta of […]
DaVita (NYSE:DVA – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 9.000-9.800 for the period, compared to the consensus estimate of 9.010. The company issued revenue guidance of -. DaVita Price Performance Shares of NYSE:DVA traded down $10.04 during midday trading on Friday, […]
IFM Investors Pty Ltd lessened its stake in shares of DaVita Inc. (NYSE:DVA – Free Report) by 1.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,658 shares of the company’s stock after selling 256 shares during the quarter. IFM Investors Pty […]